What are the side effects of systemic treatments?

The Psoriasis Strategy™ By Julissa Clay This eBook is known as a reliable source to help you in getting your psoriasis cured day by day. Thousands of people have used it to cure their irritable and annoying skin condition by following the instructions provided in this eBook. In this eBook, its creator has provided complete information about this skin condition and its causes. She has suggested the ways which you can follow to cure the condition of your skin without worsening its condition or harming your skin.

What are the side effects of systemic treatments?

Systemic treatments for psoriasis are powerful medications that work throughout the body and are used primarily for moderate to severe cases of the condition. While they are highly effective, they come with potential side effects that can range from mild to severe. Here’s a detailed overview of the side effects associated with the different types of systemic treatments for psoriasis:

1. Traditional Systemic Treatments

a. Methotrexate

Common Side Effects:
- Gastrointestinal Issues: Nausea, vomiting, diarrhea, and mouth sores are common.
- Fatigue: Patients often experience fatigue and malaise.
Serious Side Effects:
- Liver Toxicity: Methotrexate can cause elevated liver enzymes and long-term liver damage, including fibrosis and cirrhosis. Regular liver function tests are required.
- Bone Marrow Suppression: This can lead to anemia, leukopenia (low white blood cell count), and thrombocytopenia (low platelet count), increasing the risk of infections and bleeding.
- Pulmonary Toxicity: Methotrexate can cause lung inflammation and fibrosis.
- Infections: Due to its immunosuppressive effects, methotrexate increases the risk of infections.

b. Cyclosporine

Common Side Effects:
- Hypertension: Elevated blood pressure is a frequent side effect.
- Hypertrichosis: Increased hair growth can occur.
Serious Side Effects:
- Nephrotoxicity: Cyclosporine can cause kidney damage, leading to impaired renal function. Regular monitoring of kidney function is necessary.
- Increased Risk of Infections: Immunosuppression increases susceptibility to infections.
- Neurological Effects: Headaches, tremors, and seizures can occur.
- Electrolyte Imbalances: Hyperkalemia (high potassium levels) and hypomagnesemia (low magnesium levels) are potential side effects.
- Gingival Hyperplasia: Overgrowth of gum tissue can occur.

c. Acitretin

Common Side Effects:
- Dryness: Dry skin, lips, eyes, and mucous membranes are common.
- Hair Loss: Thinning of hair or hair loss can occur.
Serious Side Effects:
- Hepatotoxicity: Elevated liver enzymes and potential liver damage require regular monitoring.
- Hyperlipidemia: Elevated cholesterol and triglycerides levels are possible.
- Skeletal Changes: Long-term use can cause bone and joint pain, and there is a risk of ossification (bone growth) in ligaments and tendons.
- Teratogenicity: Acitretin is highly teratogenic and can cause severe birth defects. Women of childbearing potential must use effective contraception and avoid pregnancy for three years after stopping the medication.

2. Biologic Therapies

a. Tumor Necrosis Factor-alpha (TNF-α) Inhibitors

Common Side Effects:
- Injection Site Reactions: Pain, swelling, redness, and itching at the injection site.
- Upper Respiratory Infections: Common colds and sinus infections.
Serious Side Effects:
- Increased Risk of Serious Infections: Including tuberculosis (TB), fungal infections, and other opportunistic infections. Patients should be screened for TB before starting treatment.
- Demyelinating Diseases: Rarely, these drugs can trigger or worsen demyelinating diseases like multiple sclerosis.
- Heart Failure: TNF-α inhibitors can exacerbate heart failure.
- Malignancies: There is a potential increased risk of lymphomas and other malignancies.

b. Interleukin (IL) Inhibitors

IL-17 Inhibitors (e.g., Secukinumab, Ixekizumab):
- Common Side Effects: Injection site reactions, upper respiratory infections, and headaches.
- Serious Side Effects: Increased risk of infections, potential exacerbation of inflammatory bowel disease (IBD).
IL-12/23 Inhibitors (e.g., Ustekinumab):
- Common Side Effects: Upper respiratory infections, headaches, and fatigue.
- Serious Side Effects: Increased risk of infections, potential malignancy risk, and rare neurological disorders.
IL-23 Inhibitors (e.g., Guselkumab, Risankizumab):
- Common Side Effects: Upper respiratory infections, injection site reactions, and headaches.
- Serious Side Effects: Increased risk of infections and potential increase in malignancy risk.

3. Janus Kinase (JAK) Inhibitors

Example: Tofacitinib
Common Side Effects:
- Gastrointestinal Issues: Nausea, diarrhea, and abdominal pain.
- Headaches: Commonly reported by patients.
Serious Side Effects:
- Increased Risk of Serious Infections: Including TB, herpes zoster (shingles), and other opportunistic infections.
- Thrombosis: Increased risk of blood clots, including deep vein thrombosis (DVT) and pulmonary embolism (PE).
- Elevated Cholesterol: Can cause an increase in LDL cholesterol levels.
- Malignancies: Potential increased risk of certain cancers, including lymphomas.

4. Phosphodiesterase 4 (PDE4) Inhibitors

Example: Apremilast
Common Side Effects:
- Gastrointestinal Issues: Nausea, vomiting, diarrhea, and abdominal pain are common, especially during the initial stages of treatment.
- Headaches: Frequently reported by patients.
Serious Side Effects:
- Weight Loss: Some patients experience significant weight loss.
- Depression: There is a potential risk of mood changes, depression, and suicidal thoughts. Patients with a history of depression should be closely monitored.

5. General Considerations for Systemic Treatments

a. Monitoring and Regular Check-Ups

Blood Tests: Regular blood tests are required to monitor liver function, kidney function, blood cell counts, and lipid levels.
Infection Screening: Patients should be screened for infections, including TB and hepatitis, before starting treatment and monitored for signs of infection during therapy.

b. Contraindications and Precautions

Pregnancy and Breastfeeding: Many systemic treatments are contraindicated during pregnancy and breastfeeding due to potential teratogenic effects and risks to the infant.
Pre-Existing Conditions: Patients with pre-existing liver disease, kidney disease, or heart conditions require careful consideration and monitoring when using systemic treatments.

c. Patient Education

Informed Consent: Patients should be thoroughly informed about the potential benefits and risks of systemic treatments.
Adherence to Treatment: Ensuring patients understand the importance of adherence to their treatment regimen and regular monitoring is crucial for minimizing risks and maximizing efficacy.

Conclusion

Systemic treatments for psoriasis, including traditional systemic treatments and biologic therapies, offer significant benefits for managing moderate to severe psoriasis. However, they come with a range of potential side effects that require careful monitoring and management. Understanding these side effects helps in making informed decisions about treatment options and ensures that patients receive the most appropriate and effective care for their condition. Regular check-ups, patient education, and adherence to treatment protocols are essential components of successful systemic therapy for psoriasis.